Jeanne Jordan, Ph.D.

Jeanne Jordan, Ph.D.

George Washington University Milken Institute School of Public Health (GWSPH)

Jeanne Jordan, Ph.D., has 30 years of experience developing, validating and implementing molecular diagnostics for infectious diseases. She has been PI on both federally funded and non-federally funded research grants throughout her career. Her initial grants were from NIH NICHD and NIAID (R03 and R01) while at University of Pittsburgh and focused on designing a molecular approach for detecting and identifying bacterial etiologies of sepsis in neonates and adults, respectively. She spent 18 years as medical director (HCLD-ABB) for several CLIA-certified clinical laboratories when she was a tenured faculty at University of Pittsburgh Medical Center, Magee-Women’s Hospital (UPMC MWH).

There she built a molecular infectious disease diagnostics program within clinical microbiology/virology laboratory with a focus on sexually transmitted infections, maternal-infant health and hospital-acquired infections. She set up a 24/7 screening program in labor and delivery for intrapartum GBS testing and rapid HIV-1 antibody screening. She designed a molecular screening program for Trichomonas vaginalis from ED patients who had wet mount negative results. This change in algorithm resulted in doubling the number of TV infections diagnosed and treated. While at UPMC, her clinical laboratory served as an HPV DNA screening and genotyping lab for NCI ALTS trial (Solomon-PI), the NIA NSHAP studies (Lindau-PI) and Centers for Disease Control and Prevention NHANES Healthy People 2010 study (Jordan-PI). She served as Associate Director of Magee-Women’s Research Institute from 1999-2008 before leaving for GWU School of Public Health.

Since moving to GWUSPH as a tenured professor Jordan continues to be funded as PI by NIH. She is currently funded by NIH NCI R01 as PI to identify companion diagnostics to the anal Pap test to improve specificity for predicting high-grade lesion in HIV-infected men who have sex with men. Her research laboratory is certified by Immunology Quality Assurance Center at Duke University to provide sample processing, including leukopac processing for 3 national laboratory networks including HPTN, HVTN and ACTG-supported studies.

She served as site PI for several multi-site clinical trials evaluating HIV-1 Qualitative and Viral Load Assays (Cepheid) that received CE-IVD and Food and Drug Administration clearance. During the recent pandemic, her lab supported the Moderna SARS-CoV2 vaccine clinical trial as well as performed NGS of SARS-CoV-2 positive samples for variant identification and surveillance for the GWU community. Lastly, Jordan currently serves as chair for the Science Advisory Board for the District of Columbia Department of Forensic Sciences and Public Health Laboratory, and as associate editor for the Journal of Clinical Virology.